Ali Ebrahimi Fard
Isfahan University of Medical Sciences
Internal medicineOncologyIonizing radiationChemotherapyNeoadjuvant therapyDocetaxelCombination chemotherapyRadiation therapyBreast cancerMedicineCancer cell
1Publications
1H-index
4Citations
Publications 1
Newest
#1Ali Ebrahimi Fard (IUMS: Isfahan University of Medical Sciences)H-Index: 1
#2Mohamad Bagher Tavakoli (IUMS: Isfahan University of Medical Sciences)H-Index: 4
Last. Hamid Emami (IUMS: Isfahan University of Medical Sciences)H-Index: 8
view all 4 authors...
In recent decades neoadjuvant therapies such as combined chemotherapy and radiotherapy have been introduced for cancer management. Compared with monotherapy modalities, neoadjuvant therapy is associated with greater effectiveness while having minor side effects. Docetaxel is a chemotherapy agent for breast cancer treatment which can blocks the cell cycle at the G2/M phase which has shown special sensitivity to the ionizing radiation and hence causes cell death. To the best of our knowledge, ther...
4 CitationsSource